28.06.2014 Views

Autologous Bone Marrow Transplantation - Blog Science Connections

Autologous Bone Marrow Transplantation - Blog Science Connections

Autologous Bone Marrow Transplantation - Blog Science Connections

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

664 Amphotericin B for Neutropenie Fever<br />

treated patients received WBC transfusions, which have been associated in<br />

one series with an increased risk of pulmonary infiltrates (14). Pulmonary<br />

toxicity, however, has been attributed to amphotericin B even in the absence<br />

of WBC transfusion and may have contributed to the abnormal x-ray findings<br />

in some of our patients (15).<br />

Although the efficacy of empiric amphotericin B therapy in reducing the<br />

risk of invasive fungal infections cannot be assessed directly in this study, our<br />

experience is consistent with other published data that demonstrate frequent<br />

clinical improvement after amphotericin B administration. Many of our<br />

patients had intensive treatment for solid tumors, and thus belonged to a<br />

group not usually at risk for invasive fungal infection during therapy. Toxicity,<br />

moreover, was acceptable in our patients despite the use of rapid infusion<br />

rates since only two patients required discontinuation of antifungal drug<br />

owed to adverse reactions. Empiric amphotericin B therapy for unexplained<br />

neutropenic fever is a safe and effective treatment for patients undergoing<br />

intensive antitumor chemoradiotherapeutic regimens. We are conducting<br />

additional studies of the role of surveillance fungal cultures or fungal<br />

serologic studies to define more specific indications for amphotericin B<br />

therapy in neutropenic patients.<br />

REFERENCES<br />

1. Gerson SL, Talbot GH, Hurwitz S, Strom BL, Lusk EJ, Cassileth PA. Ann Intern Med<br />

1984:100:345.<br />

2. GoldJWM. AmJ Med 1984:76:458.<br />

3. Holleran WM, Wilbur JR, DeGregorio MW. Rev Infect Dis 1985:7:619.<br />

4. DeGregorio MW, Lee WMF, Linker CA, Jacobs RA, Ries CA. Am J Med 1982;73:543.<br />

5. Pizzo PA, Robichaud KJ, Gill FA, Witebsky FG. Am J Med 1982;72:101.<br />

6. Joshi JH, Schimpff SC, Tenney JH, Newman KA, de Jongh CA. Am J Med 1984;76:450.<br />

7. Stein RS, Kayser J, Flexner JM. Cancer 1982:50:2247.<br />

8. Lazarus HM, Lowder JN, Anderson JM, Herzig RH. JPEN 1984;8:501.<br />

9. Burks LC, Aisner J, Former CL, Wiernik PH. Arch Intern Med 1980:140:483.<br />

10. Smith CR, LipskyJJ, Laskin OL, Hellmann DB, Mellits ED, Longstreth J, Lietman PS. N Engl<br />

J Med 1980:302:1106.<br />

11. O'Regan S, Carson S, Chesney RW, Drummond KN. Blood 1977;49:345.<br />

12. BlachleyJD, HillJB. Ann Intern Med 1981:95:628.<br />

13. Barton CH, Pahl M, Vaziri ND, Cesario T. Am J Med 1984;77:471.<br />

14. Wright DG, Robichaud KJ, Pizzo PA, Deisseroth AB. N Engl J Med 1981 ;304:1185.<br />

15. Habner RH, Oddone EZ, Gurbel PA, Stead WW. N Engl J Med 1986:315:836 (letter).

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!